Navigation Links
Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals
Date:1/5/2009

rrent reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, particularly the discussion under the caption "Item 1A, RISK FACTORS" in our annual report on Form 10-K/A for the year ended December 31, 2007, which was filed with the Securities and Exchange Commission on April 29, 2008. The forward-looking statements in this press release and on the related conference call are qualified by these risk factors. These are factors that, individually or in the aggregate, we think could cause our actual results to differ materially from expected and historical results. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Tender Offer Statement

This communication is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell any shares of Indevus common stock. The tender offer described herein has not yet been commenced. On the commencement date of the tender offer, an offer to purchase, a letter of transmittal and related documents will be filed with the Securities and Exchange Commission ("SEC"), will be mailed to Indevus stockholders and will also be made available for distribution to beneficial owners Indevus common stock. The solicitation of offers to buy shares of Indevus common stock will only be made pursuant to the offer to purchase, the letter of transmittal and related documents. Indevus stockholders are strongly advised to read both the tender offer statement on Schedule TO, as it may be amended from time to time, and the solicitation/recommendation statement on Schedule 14D-9, as it may be amended from time to time, regarding the tender offer when they become available as they will contain important information, including the various terms of, and conditions to, the tender offer. The tender offer statement will be filed by Endo and BTB Purchaser Inc. with th
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014 A group of 127 scientists ... today, in reaction to a recent statement by the center ... training and derogated the efficacy of all brain exercises. , ... the parts of the center’s statement critical of brain exercise ... had also overstated its case, in a document it had ...
(Date:12/17/2014)... 2014 Project Veritas is releasing a ... of MIT economist and Obamacare architect Jonathan Gruber to ... conducted the interview, which is being distributed on YouTube. ... intentional mislabeling in the Affordable Care Act in order ... two-hundred-and-fifty billion dollar per year tax grab. , “President ...
(Date:12/17/2014)... -- Poor students get more fruits and vegetables at school ... But, the opposite is true for students from wealthier families. ... school may give a healthy boost to poor students, diets, ... family income level, students all ate a similar amount of ... study was published recently in the journal Preventive Medicine ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. ... in America, and work commitment is a big reason why, ... killer," said Dr. Mathias Basner, an assistant professor of sleep ... School of Medicine. A time-use survey of nearly 125,000 ... the main activity exchanged for sleep. Short sleepers -- those ...
(Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ), Unionville’s first ... study providing evidence on the impact of 100% pure ... Sufficient enough evidence already exists showing a negative link ... with the onset of tooth decay. One question that ... 100% fruit juice, meaning it is completely natural with ...
Breaking Medicine News(10 mins):Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Poor Students Eat Healthier Foods at School, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2
... Equipment,s LC Sprint reusable nebulizer and TREK S portable compressor ... of "ER" that will air Thursday at 9pm on NBC. ... of "ER," including George Clooney and Julianna Margulies, so the ... PARI nebulizers have been used on the show to highlight ...
... the House Subcommittee on Oversight and Investigations, Coast IRB ... immediate and sweeping reforms. "We share Congress,s objective ... trials," said Dueber. "We are instituting comprehensive reforms ... to light," he said. "Our number one priority ...
... researchers say , , MONDAY, March 30 (HealthDay News) Action ... the pastime can help adults improve a part of eyesight ... to be affected by aging. , Contrast sensitivity -- ... grey against a uniform background -- is important in situations ...
... Drug Discovery Activities in Neurodegenerative Diseases-ROCKLAND, Mass., March ... it will open a site in Cambridge, Massachusetts ... Cambridge laboratory space will accommodate EMD Serono,s US ... multiple sclerosis (MS), which will augment the company,s ...
... (Nasdaq: NUVA ), a medical device company ... for the spine, announced today that due to the ... accelerated the transfer of the processing of Osteocel Plus ... its own exclusive supply chain. Since the May 2008 ...
... March 30 The U.S. Preventive Services Task Force ... appropriate systems are in place to ensure accurate diagnosis, ... adolescents 12 to 18 years of age. In ... to assess the balance of benefits and harms of ...
Cached Medicine News:Health News:PARI's LC Sprint & TREK S Featured in 'ER' Final Episode on NBC Thursday 2Health News:EMD Serono, Inc. Announces Expansion with Research Site in Cambridge, Massachusetts 2Health News:EMD Serono, Inc. Announces Expansion with Research Site in Cambridge, Massachusetts 3Health News:Long Term Supply of Osteocel(R) Plus Solidified Without Ownership of Processing Facility 2Health News:Long Term Supply of Osteocel(R) Plus Solidified Without Ownership of Processing Facility 3Health News:Long Term Supply of Osteocel(R) Plus Solidified Without Ownership of Processing Facility 4Health News:Task Force Recommends Screening Adolescents for Clinical Depression 2Health News:Task Force Recommends Screening Adolescents for Clinical Depression 3
(Date:12/15/2014)... and Markets , http://photos.prnewswire.com/prnh/20130307/600769 ... the addition of the "Cardiac Guidewires - Global ... Global Guidewires sector is projected to reach US$1.6 ... accounts for nearly 35% (2015) of the global ... 25% (2018). Asia-Pacific is the ...
(Date:12/15/2014)... 15, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... added to the NASDAQ Biotechnology Index (NBI). The ... effective upon market open on December 22, 2014. ... to track the performance of a set of ... or pharmaceutical according to the Industry Classification Benchmark. ...
(Date:12/15/2014)... , December 15, 2014 Investor-Edge ... ZGNX ), Eli Lilly and Company (NYSE: ... Sanofi (NYSE: SNY ), and Novartis AG (NYSE: ... can be accessed at: http://investor-edge.com/register . On ... down 1.16%, the Dow Jones Industrial Average lost 1.79%, to ...
Breaking Medicine Technology:Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5
... , , LAKE MARY, Fla., Dec. 22 Access ... outsourced implantable medical device management solutions to the healthcare ... Partners in Focus online portal will be ... MediQuip provides implantable device management solutions that allow surgeries ...
... 22 Unilens Vision Inc. (OTC Bulletin Board: UVICF; TSX ... Vision Inc. voted overwhelmingly in favor of the resolution to ... of its shareholders held yesterday. Of the 2,361,854 common shares ... voted at the meeting with 1,141,138 (or 98.8%) voted in ...
Cached Medicine Technology:Access MediQuip Announces Release of Partners in Focus Provider Portal 2Unilens Announces Extraordinary Meeting Results 2
... Biotech Mumps IgM Enzyme-Linked Immunosorbent ... the qualitative detection of IgM ... Mumps for the determination of ... of this kit have not ...
The DSL 05-10-MUM Mumps IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Mumps virus in human serum. This assay is intended for in...
... announced the launch of the Chilli ... bi-directional cooled-tip catheter available in the United ... physicians the benefits of cooled ablation technology ... Boston Scientific Blazer(R) catheter platform. ,Cooled cardiac ...
... BareWire technology, the wire crosses the lesion ... catheter. All other actions, including filter placement ... then occur over the wire., ,Emboshield is ... off during a carotid stenting procedure, and ...
Medicine Products: